Literature DB >> 12367531

X-ray crystal structure of the C4d fragment of human complement component C4.

Jean M H van den Elsen1, Alberto Martin, Veronica Wong, Liliana Clemenza, David R Rose, David E Isenman.   

Abstract

C4 fulfills a vital role in the propagation of the classical and lectin pathways of the complement system. Although there are no reports to date of a C4 functional activity that is mediated solely by the C4d region, evidence clearly points to it having a vital role in a number of the properties of native C4 and its major activation fragment, C4b. Contained within the C4d region are the thioester-forming residues, the four isotype-specific residues controlling the C4A/C4B transacylation preferences, a binding site for nascent C3b important in assembling the classical pathway C5 convertase and determinants for the Chido/Rodgers (Ch/Rg) blood group antigens. In view of its functional importance, we undertook to determine the three-dimensional structure of C4d by X-ray crystallography. Here we report the 2.3A resolution structure of C4Ad, the C4d fragment derived from the human C4A isotype. Although the approximately 30% sequence identity between C4Ad and the corresponding fragment of C3 might be expected to establish a general fold similarity between the two molecules, C4Ad in fact displays a fold that is essentially superimposable on the structure of C3d. By contrast, the electrostatic characteristics of the various faces of the C4Ad molecule show marked differences from the corresponding faces of C3d, likely reflecting the differences in function between C3 and C4. Residues previously predicted to form the major Ch/Rg epitopes were proximately located and accessible on the concave surface of C4Ad. In addition to providing further insights on the current models for the covalent binding reaction, the C4Ad structure allows one to rationalize why C4d is not a ligand for complement receptor 2. Finally the structure allows for the visualization of the face of the molecule containing the binding site for C3b utilized in the assembly of classical pathway C5 convertase.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12367531     DOI: 10.1016/s0022-2836(02)00854-9

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  14 in total

1.  Immunophysical properties and prediction of activities for vaccinia virus complement control protein and smallpox inhibitor of complement enzymes using molecular dynamics and electrostatics.

Authors:  Li Zhang; Dimitrios Morikis
Journal:  Biophys J       Date:  2006-02-10       Impact factor: 4.033

2.  alpha-Macroglobulins are present in some gram-negative bacteria: characterization of the alpha2-macroglobulin from Escherichia coli.

Authors:  Ninh Doan; Peter G W Gettins
Journal:  J Biol Chem       Date:  2008-08-12       Impact factor: 5.157

Review 3.  Do follicular dendritic cells regulate lupus-specific B cells?

Authors:  Balthasar A Heesters; Abhishek Das; Priyadarshini Chatterjee; Michael C Carroll
Journal:  Mol Immunol       Date:  2014-03-14       Impact factor: 4.407

4.  The Role of Dendritic Cells in S. pneumoniae Transport to Follicular Dendritic Cells.

Authors:  Balthasar A Heesters; Michael C Carroll
Journal:  Cell Rep       Date:  2016-09-20       Impact factor: 9.423

5.  Interaction of human complement with Sbi, a staphylococcal immunoglobulin-binding protein: indications of a novel mechanism of complement evasion by Staphylococcus aureus.

Authors:  Julia D Burman; Elisa Leung; Karen L Atkins; Maghnus N O'Seaghdha; Lea Lango; Pau Bernadó; Stefan Bagby; Dmitri I Svergun; Timothy J Foster; David E Isenman; Jean M H van den Elsen
Journal:  J Biol Chem       Date:  2008-04-22       Impact factor: 5.157

6.  Human alpha2-macroglobulin is composed of multiple domains, as predicted by homology with complement component C3.

Authors:  Ninh Doan; Peter G W Gettins
Journal:  Biochem J       Date:  2007-10-01       Impact factor: 3.857

7.  Complete sequencing and expression of three complement components, C1r, C4 and C1 inhibitor, of the classical activation pathway of the complement system in rainbow trout Oncorhynchus mykiss.

Authors:  Tiehui Wang; Christopher J Secombes
Journal:  Immunogenetics       Date:  2003-11-20       Impact factor: 2.846

8.  Renal allograft pathology with C4d immunostaining in patients with graft dysfunction.

Authors:  P Kulkarni; M S Uppin; A K Prayaga; U Das; K V Dakshina Murthy
Journal:  Indian J Nephrol       Date:  2011-10

9.  The structure of OMCI, a novel lipocalin inhibitor of the complement system.

Authors:  Pietro Roversi; Olga Lissina; Steven Johnson; Nurfilza Ahmat; Guido C Paesen; Kerstin Ploss; Wilhelm Boland; Miles A Nunn; Susan M Lea
Journal:  J Mol Biol       Date:  2007-03-30       Impact factor: 5.469

10.  Complement C4A Regulates Autoreactive B Cells in Murine Lupus.

Authors:  Léa Simoni; Jessy Presumey; Cees E van der Poel; Carlos Castrillon; Sarah E Chang; Paul J Utz; Michael C Carroll
Journal:  Cell Rep       Date:  2020-11-03       Impact factor: 9.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.